Gene · 51755
Papers3,441
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 3,441
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Context-aware gene dependency modeling via graph attention networks for precision oncology. | J Transl Med | 2025 | 41291726 | PubTator, text mining | PubMed |
| WEE1 inhibitors trigger GCN2-mediated activation of the integrated stress response. | Nat Commun | 2025 | 41285872 | PubTator, text mining | PubMed |
| BrUOG360: A Phase Ib/II Study of Copanlisib in Combination with Rucaparib in Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC). | Cancer Res Commun | 2025 | 41231232 | PubTator, text mining | PubMed |
| Blood-Based Genomic Alteration Signature for Predicting Progression-Free Survival in De Novo Metastatic Hormone-Sensitive Prostate Cancer: A Real-World Study. | Cancer Res Commun | 2025 | 41217768 | PubTator, text mining | PubMed |
| CDK12 as a Potential Biomarker for Characterization of Circulating Tumor Cells in Epithelial Ovarian Tumors. | Curr Mol Med | 2025 | 41177788 | PubTator, text mining | PubMed |
| CDK12 inhibition reveals melanoma dependence on the RUNX1/CBFβ complex for genomic stability. | Cell Rep | 2025 | 41176765 | PubTator, text mining | PubMed |
| Genomic landscape of cancer driver genes in Omani breast cancers: a pilot study. | Breast Cancer Res | 2025 | 41057920 | PubTator, text mining | PubMed |
| DNA damage-dependent mechanisms of ionizing radiation-induced cellular senescence. | PeerJ | 2025 | 41048400 | PubTator, text mining | PubMed |
| Dual Modes of Gene Regulation by CDK12. | bioRxiv | 2025 | 41040222 | PubTator, text mining | PubMed |
| Pathogenic variants reveal candidate genes for prostate cancer germline testing for men of African ancestry. | Nat Commun | 2025 | 41038821 | PubTator, text mining | PubMed |
| Leveraging Real-World Data From a Clinicogenomic Database Addresses the Treatment Gap in Patients With High-Grade Serous Ovarian Cancer. | JCO Precis Oncol | 2025 | 41004702 | PubTator, text mining | PubMed |
| Loss of the tumor suppressor PTEN activates cell-intrinsic interferon signaling to drive immune resistance. | bioRxiv | 2025 | 41000885 | PubTator, text mining | PubMed |
| CDK12 regulates cellular metabolism to promote glioblastoma growth. | JCI Insight | 2025 | 40996961 | PubTator, text mining | PubMed |
| CCDC137 knockdown suppresses bladder cancer progression by downregulating SCD. | J Transl Med | 2025 | 40993629 | PubTator, text mining | PubMed |
Complete remission with olaparib in BRIP1-mutated metastatic high-grade pleomorphic sarcoma: case study and literature review - an example of a genomic profiling-based tumor treatment, in a cancer type with high unmet clinical need. | Acta Oncol | 2025 | 40988318 | PubTator, text mining | PubMed |
| Transcription quality control at the promoter-proximal checkpoint. | Genes Dev | 2025 | 40973501 | PubTator, text mining | PubMed |
| CDK12/13 inactivation triggers STING-mediated antitumor immunity in preclinical models. | J Clin Invest | 2025 | 40955658 | PubTator, text mining | PubMed |
| Resistance to CDK7 inhibitors directed by acquired mutation of a conserved residue in cancer cells. | EMBO J | 2025 | 40921851 | PubTator, text mining | PubMed |
| Multiple myeloma associated long non-coding RNA PLUM confers chemoresistance by enhancing PRC2 mediated UPR pathway activation. | Nat Commun | 2025 | 40890111 | PubTator, text mining | PubMed |
| WEE1 inhibitor exerts synergistic effect with KRAS G12C inhibitor via MYBL2-RRM2 axis in KRASG12C-mutant lung cancer. | Cell Death Dis | 2025 | 40885709 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51755/papers?page=8